Intraoperative Different Fluid Therapy Protocols

Not Applicable

Completed

• Conditions: Intraoperative Fluid Management
• Interventions: Other: Restricted Fluid Administration

• Registration Number: NCT06188299
• Lead Sponsor: Ankara City Hospital Bilkent

Brief Summary

We aimed to evaluate the relationship between different intraoperative fluid therapy protocols and postoperative renal damage and mortality.

Detailed Description

Sixty patients who 18-65 age and underwent pancreatic surgery in our hospital were included in the study. They were divided into two groups as liberal fluid therapy (Group 1, n=30) and targeted fluid therapy (Group 2, n=30).

Study Timeline

• Study Start: 2022-01-20
• Primary Completion: 2022-12-01
• Study Completion: 2023-05-15
• Study First Submitted: 2023-12-18
• Study First Submitted QC: 2023-12-18
• Study First Posted: 2024-01-03
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-16
• Last Update Posted: 2024-07-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Planned pancreatic surgery

Exclusion Criteria

• No exclusion criteria was presetted.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Targeted Fluid Therapy	Restricted Fluid Administration	Targeted (restrictive) Fluid therapy was administered to this group. Fluids were given according to targeted blood pressure levels and aimed to avoid from fluid overload.

Primary Outcome Measures

Name	Time	Method
AKI	72 Hour	Postoperative Renal Injury
Mortality	72 Hour	Intraoperative and Postoperative Mortality Rate

Secondary Outcome Measures

Name	Time	Method
Blood Loss	Intraoperative period	Intraoperative total blood loss

Trial Locations

Locations (1)

Ankara Bilkent Şehir Hastanesi; 🇹🇷 Ankara, Turkey